Letteratura scientifica selezionata sul tema "He53"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Consulta la lista di attuali articoli, libri, tesi, atti di convegni e altre fonti scientifiche attinenti al tema "He53".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Articoli di riviste sul tema "He53"
Kent, Matthew R., Delia Calderon, Katherine M. Silvius, Jack P. Kucinski, Collette A. LaVigne, Matthew V. Cannon e Genevieve C. Kendall. "Abstract 3533: Zebrafish her3 knockout impacts developmental and rhabdomyosarcoma-related gene signatures". Cancer Research 83, n. 7_Supplement (4 aprile 2023): 3533. http://dx.doi.org/10.1158/1538-7445.am2023-3533.
Testo completoBeckford Vera, Denis, Jason Li, Le-Cun Xu, Debbie Lewis, Amanda Chin, Patrik Brodin, Mary Chen, Monideepa Roy e Helen Kotanides. "Preclinical evaluation of novel HER3-targeting radioconjugates for the imaging and treatment of HER3-expressing cancers." Journal of Clinical Oncology 41, n. 16_suppl (1 giugno 2023): e15114-e15114. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e15114.
Testo completoKoyama, Kumiko, Hirokazu Ishikawa, Manabu Abe, Yoshinobu Shiose, Suguru Ueno, Yang Qiu, Kenji Nakamaru e Masato Murakami. "Patritumab deruxtecan (HER3-DXd), a novel HER3 directed antibody drug conjugate, exhibits in vitro activity against breast cancer cells expressing HER3 mutations with and without HER2 overexpression". PLOS ONE 17, n. 5 (3 maggio 2022): e0267027. http://dx.doi.org/10.1371/journal.pone.0267027.
Testo completoKomatsu, Nagiho, Saori Sato, Sumie Muramatsu, Ryuichi Nakamura e Kumiko Koyama. "Abstract 3996: The impact of HER3 dynamics on the efficacy of HER3-DXd, a novel HER3 directed antibody-drug conjugate". Cancer Research 83, n. 7_Supplement (4 aprile 2023): 3996. http://dx.doi.org/10.1158/1538-7445.am2023-3996.
Testo completoO'Hare, Thomas, Jaclyn Cleveland, Valerie M. Jansen e David Dornan. "Abstract 3121: Therapeutic potential of a HER3 antibody-drug conjugate for the treatment of HER3-expressing cancers". Cancer Research 84, n. 6_Supplement (22 marzo 2024): 3121. http://dx.doi.org/10.1158/1538-7445.am2024-3121.
Testo completoBeckford-Vera, Denis, Megan McCloskey, Jason Li, Caroline Jennings, Le-Cun Xu, Debbie Lewis, Patrik Brodin et al. "Abstract 5040: Novel HER3 targeting antibody radioconjugates, 225Ac-HER3 ARC and 177Lu-HER3 ARC, exhibit potent antitumor efficacy in HER3-positive solid tumors". Cancer Research 83, n. 7_Supplement (4 aprile 2023): 5040. http://dx.doi.org/10.1158/1538-7445.am2023-5040.
Testo completoToy, Weiyi, Dipti Thakkar, Roberto Magallanes, Sharon Wu, Ming Poi, Alejandro Mas, Konrad Paszkiewicz, Piers Ingram e Jerome Boyd-Kirkup. "Abstract 5796: A HER3 antibody that uniquely blocks the HER3 heterodimerization interface effectively inhibits tumor growth in pre-clinical models with potentially oncogenic HER3 mutations". Cancer Research 84, n. 6_Supplement (22 marzo 2024): 5796. http://dx.doi.org/10.1158/1538-7445.am2024-5796.
Testo completoBeckford-Vera, Denis, Jason Li, Megan McCloskey, Caroline Jennings, Amanda Chin, Qing Liang, Jesse Hwang, Monideepa Roy, Mary Chen e Helen Kotanides. "Abstract 3306: Targeting HER3 receptor positive cancers with a novel anti-HER3 antibody radioconjugate (ARC)". Cancer Research 82, n. 12_Supplement (15 giugno 2022): 3306. http://dx.doi.org/10.1158/1538-7445.am2022-3306.
Testo completoScartozzi, M., A. Mandolesi, R. Giampieri, A. Zaniboni, E. Galizia, L. Giustini, R. R. Silva, R. Berardi, I. Bearzi e S. Cascinu. "The role of HER-3 expression in the prediction of clinical outcome for advanced colorectal cancer patients receiving irinotecan/cetuximab." Journal of Clinical Oncology 29, n. 4_suppl (1 febbraio 2011): 404. http://dx.doi.org/10.1200/jco.2011.29.4_suppl.404.
Testo completoMartinez Lago, Nieves, Ihab Abdulkader, Dora Insua Santamaria, Patricia Viaño Nuñez, Juan Jose Carrera, Jose Ramón Antunez Lopez, Maria Elena Padin Iruegas e Rafael López López. "Assessment and prognostic impact of a new classification using HER2 and HER3 status in resected gastric cancer in a european cohort." Journal of Clinical Oncology 36, n. 4_suppl (1 febbraio 2018): 65. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.65.
Testo completoTesi sul tema "He53"
BON, GIULIA. "Dual targeting of HER3 and MEK may overcome HER3-dependent chemoresistance of colon cancers". Doctoral thesis, Università degli Studi di Roma "Tor Vergata", 2013. http://hdl.handle.net/2108/202145.
Testo completoAldana, Hidalgo Julio Xavier, Parodi Augusto José Amador, Palacios Jorge Martin Arredondo, Aguilar Carla Barrionuevo, Ortiz Carol Elizabeth Beltrán, Fuentes Carlos Arturo Capellino, Alcazar Martin Roberto Cervetto et al. "Estrategias de redacción - HE59 201801". Universidad Peruana de Ciencias Aplicadas (UPC), 2018. http://hdl.handle.net/10757/624389.
Testo completo(UPC), Universidad Peruana de Ciencias Aplicadas, e Celis Ingunza Sandy Cecilia. "Creatividad Y Liderazgo-HE50-201601". Universidad Peruana de Ciencias Aplicadas (UPC), 2016. http://hdl.handle.net/10757/639326.
Testo completo(UPC), Universidad Peruana de Ciencias Aplicadas, e Garcia Soria Juddy Grethel Nora. "Creatividad Y Liderazgo-HE50-201602". Universidad Peruana de Ciencias Aplicadas (UPC), 2016. http://hdl.handle.net/10757/639327.
Testo completo(UPC), Universidad Peruana de Ciencias Aplicadas, e Ilizarbe Jurado Anndy Antonio. "Creatividad Y Liderazgo-HE50-201701". Universidad Peruana de Ciencias Aplicadas (UPC), 2017. http://hdl.handle.net/10757/639328.
Testo completoBass, Tarek. "Affibody molecules targeting HER3 for cancer therapy". Doctoral thesis, KTH, Proteinteknologi, 2017. http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-204593.
Testo completoQC 20170330
Htun, van der Horst Edward. "The role of ErbB3/HER3 in gliomas and breast cancer". Diss., lmu, 2002. http://nbn-resolving.de/urn:nbn:de:bvb:19-5804.
Testo completoClaus, J. "The pseudokinase HER3 : structure/function relationships and inhibitor-induced signalling". Thesis, University College London (University of London), 2014. http://discovery.ucl.ac.uk/1457524/.
Testo completoFranks, P. W. "A He3 magnetometer for the EDM experiment". Thesis, University of Sussex, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.304321.
Testo completoXie, Ting. "Targeting `Undruggable' Cancer Proteins with Irreversible Small Molecule Inhibitors: Her3 and KRas". Thesis, Harvard University, 2014. http://dissertations.umi.com/gsas.harvard:11384.
Testo completoChemistry and Chemical Biology
Libri sul tema "He53"
cai, Jin sheng. Ping di ke ^wei guan jing ji xue~ (di4 he5 ban) bi ji he ke hou xi ti xiang jie. Bei jing: Zhong guo shi hua chu ban she, 2006.
Cerca il testo completoKay, Bartholomew L., a cura di. Planning health promotion programs: An intervention mapping approach. San Francisco: Jossey-Bass, 2006.
Cerca il testo completoSole, Kathy. Making Connections: Understanding Interpersonal Communications. Zovio Inc., 2011.
Cerca il testo completoMaking Meaning, Making Sense: Children's Early Language Learning. Zovio Inc., 2012.
Cerca il testo completoFinancial Management of Health Care Organizations: An Introduction to Fundamental Tools, Concepts and Applications. Wiley & Sons, Incorporated, John, 2020.
Cerca il testo completoFinancial Management of Health Care Organizations: An Introduction to Fundamental Tools, Concepts and Applications. Wiley & Sons, Limited, John, 2020.
Cerca il testo completoKaya, Gökalp. He3. Independently Published, 2020.
Cerca il testo completoFischer, Benjamin. He3 the Novel. Independently Published, 2017.
Cerca il testo completoHe3: The Novel. Independent Publisher, 2010.
Cerca il testo completoPopkin, Michael H. Preparation for Active Parenting/He23. South-Western Pub, 1988.
Cerca il testo completoCapitoli di libri sul tema "He53"
Lugovskoy, Alexey, Michael Curley, Johanna Lahdenranta, Ashish Kalra, Akos Czibere, Gavin MacBeath e Birgit Schoeberl. "HER3". In Cancer Therapeutic Targets, 719–37. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4419-0717-2_95.
Testo completoLugovskoy, Alexey, Michael Curley, Johanna Lahdenranta, Ashish Kalra, Akos Czibere, Gavin MacBeath e Birgit Schoeberl. "HER3". In Cancer Therapeutic Targets, 1–19. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4614-6613-0_95-1.
Testo completoMacLeod, Sheena H., Kyle G. Potts, Shyambabu Chaurasiya e Mary M. Hitt. "Assessment of Specificity of an Adenovirus Targeted to HER3/4". In Methods in Molecular Biology, 275–93. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-7219-7_18.
Testo completoHeindler, Manfred. "Feasibility, Safety and Environmental Aspects of D-He3 Fusion". In Safety, Environmental Impact, and Economic Prospects of Nuclear Fusion, 173–79. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4613-0619-1_11.
Testo completoKartavtsev, O. I. "Universal description of the He3 system at low energy". In Few-Body Problems in Physics ’98, 199–202. Vienna: Springer Vienna, 1999. http://dx.doi.org/10.1007/978-3-7091-6798-4_33.
Testo completoRostoker, Norman, e Michl Binderbauer. "Self-Colliding Beams as an Alternative Fusion System for D-He3 Reactors". In Current Trends in International Fusion Research, 33–41. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4615-5867-5_4.
Testo completoMoldover, M. R., e W. A. Little. "Specific Heat of He3 and He4 in the Neighborhood of their Critical Points". In From High-Temperature Superconductivity to Microminiature Refrigeration, 53–55. Boston, MA: Springer US, 1996. http://dx.doi.org/10.1007/978-1-4613-0411-1_7.
Testo completoSarkar, Mitul, e John G. Koland. "Fluorescence Recovery After Photobleaching Analysis of the Diffusional Mobility of Plasma Membrane Proteins: HER3 Mobility in Breast Cancer Cell Membranes". In Methods in Molecular Biology, 97–105. New York, NY: Springer New York, 2016. http://dx.doi.org/10.1007/978-1-4939-3170-5_9.
Testo completo"HER3". In Encyclopedia of Cancer, 1680. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_2678.
Testo completoHesketh, Robin. "HER3/ERbB-3". In The Oncogene & Tumour Suppressor Gene Factsbook, 212–15. Elsevier, 1997. http://dx.doi.org/10.1016/b978-012344548-3/50043-1.
Testo completoAtti di convegni sul tema "He53"
Chen, Min. "Influence of Helium Cluster Structure on Diffusion Behavior". In 2013 21st International Conference on Nuclear Engineering. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/icone21-15478.
Testo completoKol, Arjan, Martin Pool, Steven de Jong, Elisabeth GE de Vries, Marjolijn N. Lub-de Hooge e Anton GT Terwisscha van Scheltinga. "Abstract LB-B11: Assessment of HER3 status during lapatinib treatment in HER3-positive breast cancer using 89Zr-anti-HER3 mAb". In Abstracts: AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; November 5-9, 2015; Boston, MA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1535-7163.targ-15-lb-b11.
Testo completoHettmann, Thore, Matthias Schneider, Selam Ogbagabriel, Jiansong Xie, Gloria Juan, Susanne Hartmann, Robert Radinsky e Daniel J. Freeman. "Abstract LB-306: U3-1287 (AMG 888), a fully human anti-HER3 mAb, inhibits HER3 activation and induces HER3 internalization and degradation". In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-lb-306.
Testo completoGhoranneviss, Mahmoud, Babak Malekynia, Nader Azizi, Henrich Hora e George H. Miley. "Alternative Laser Driven Fusion Reactions for Nuclear Energy Without Radioactivity". In 18th International Conference on Nuclear Engineering. ASMEDC, 2010. http://dx.doi.org/10.1115/icone18-29945.
Testo completo"HE3: power measurements". In Proceedings of the 21st IEEE Instrumentation and Measurement Technology Conference. IEEE, 2004. http://dx.doi.org/10.1109/imtc.2004.1351506.
Testo completo"HE5: temperature measurement". In Proceedings of the 21st IEEE Instrumentation and Measurement Technology Conference. IEEE, 2004. http://dx.doi.org/10.1109/imtc.2004.1351517.
Testo completoPinzon-Ortiz, Maria C., Xianhui Rong, Richard Versace, Qing Sheng e Z. Alexander Cao. "Abstract 5320: Targeting HER3 and EGFR in NRG1 positive and HER3 mutated lung squamous cell carcinoma". In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-5320.
Testo completoMukherjee, A., Y. Badal, X. Nguyen, J. Miller, S. Pidaparthi, L. Chen, A. Newton, J. Cheung, G. Parry e S. Williams. "Proximity-based assays for the detection of activated HER3, HER2/HER3 heterodimers and HER3/PI3K complexes in formalin-fixed, paraffin-embedded cell line controls and tumors." In CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts. American Association for Cancer Research, 2009. http://dx.doi.org/10.1158/0008-5472.sabcs-4040.
Testo completoZhang, Weixing, Way Kuo e Victor M. Tamashunas. "Simulating the (HE3/HE3/S):(PRP/ ∞ / ∞) queuing model for a maintenance problem". In the 17th conference. New York, New York, USA: ACM Press, 1985. http://dx.doi.org/10.1145/21850.253317.
Testo completoGarrett, Joan T., Cammie R. Sutton, Carl Uli Bialucha, Seth A. Ettenberg, Jerry Wallweber, Lisa DeFazio-Eli e Carlos L. Arteaga. "Abstract 5461: A HER3 antibody that blocks ligand-independent HER2-HER3 dimerization sensitizes to HER2 and PI3K inhibitors ." In Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC. American Association for Cancer Research, 2013. http://dx.doi.org/10.1158/1538-7445.am2013-5461.
Testo completoRapporti di organizzazioni sul tema "He53"
Lyerly, H. K. Developing a HER3 Vaccine to Prevent Resistance to Endocrine Therapy. Fort Belvoir, VA: Defense Technical Information Center, ottobre 2014. http://dx.doi.org/10.21236/ada612924.
Testo completoLyerly, H. K. Developing a HER3 Vaccine to Prevent Resistance to Endocrine Therapy. Fort Belvoir, VA: Defense Technical Information Center, ottobre 2013. http://dx.doi.org/10.21236/ada597890.
Testo completoDittrich, T. R., B. A. Hammel e C. J. Keane. Diagnosis of pusher-fuel mix in indirectly driven Nova implosions (HEP3). Office of Scientific and Technical Information (OSTI), giugno 1996. http://dx.doi.org/10.2172/376961.
Testo completoOng, Nai P. Acquisition of He3 Cryostat Insert for Experiments on Topological Insulators. Fort Belvoir, VA: Defense Technical Information Center, gennaio 2016. http://dx.doi.org/10.21236/ad1007436.
Testo completoTrichtchenko, L., L. Nikitina e M. Harrison. Statistical analysis of space environment on highly elliptical orbits. HEO1 and HEO3 missions data. Natural Resources Canada/ESS/Scientific and Technical Publishing Services, 2013. http://dx.doi.org/10.4095/292717.
Testo completo